# Creatine Monohydrate Use for Preventing Altitude Induced Depression

> **NCT03433651** · PHASE4 · WITHDRAWN · sponsor: **Mike O'Callaghan Military Hospital**

## Conditions studied

- Depression

## Interventions

- **DRUG:** Creatine monohydrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03433651
- **Lead sponsor:** Mike O'Callaghan Military Hospital
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-01-07
- **Final completion:** 2019-01-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to locate grant funding.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433651, "Creatine Monohydrate Use for Preventing Altitude Induced Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03433651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*